• Molecular NameLymecycline
  • Synonym7-Chlorotetracycline; Chlorotetracycline; Chlorotetracycline hydrochloride; Chlortetracyclin; Chlortetracycline; Chlortetracycline hydrochloride; Chlortetracyclinium chloride; CLTC
  • Weight602.641
  • Drugbank_IDDB00256
  • ACS_NO992-21-2
  • Show 3D model
  • LogP (experiment)-3.2
  • LogP (predicted, AB/LogP v2.0)-3.03
  • pkaN/A
  • LogD (pH=7, predicted)-4.1
  • Solubility (experiment)Soluble (at all physiological pH values)
  • LogS (predicted, ACD/Labs)(ph=7)-2.07
  • LogSw (predicted, AB/LogsW2.0)2.9
  • Sw (mg/ml) (predicted, ACD/Labs)4.01
  • No.of HBond Donors10
  • No.of HBond Acceptors14
  • No.of Rotatable Bonds10
  • TPSA242.98
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA tetracycline broad-spectrum antibiotic
  • Absorption_value100.0
  • Absorption (description)Absorption is fast and efficient. Bioavailability is 100% following oral administration.
  • Caco_2N/A
  • Bioavailability100.0
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityAdverse effects include nausea, vomiting, diarrhoea, glossitis, enterocolitis, dysphagia, dermatitis, hypersensitivity reactions, proctitis, and vaginitis.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A